Cancer Drug Holds New Potential in Treating Alzheimer’s Disease: Animal Study

Researchers from Stanford University found that drugs originally developed for cancer treatment, known as IDO1 inhibitors, could restore memory function and improve brain metabolism in preclinical trials, according to a new study published in the journal Science. This class of drugs “wake up immune cells in cancer” and restore glucose metabolism in the brain by targeting a process known as the kynurenine pathway, Katrin Andreasson, the study’s senior author and a professor of neurology and neurological sciences at Stanford University School of Medicine, told The Epoch Times. “This helps neurons function better, leading to healthier cells that can better resist the progression of Alzheimer’s diseases,” she added....